In pharma, downtime is more than lost production
In pharmaceutical manufacturing, a faulty piece of automation isn’t just inconvenient, it’s regulatory, financial, and reputational risk rolled into one.
One small failure can trigger whole‑batch loss or a re‑validation process that takes weeks.
That’s why we exist: to keep validated automation systems running, even when the OEMs stop supporting them.
Why pharma lines rely on legacy automation
Most pharmaceutical plants run highly controlled, validated processes. Any change to a PLC or HMI can require full re‑qualification, documentation, and sign‑off which can be a lengthy, expensive exercise.
So even though a Siemens S7‑300 or Allen Bradley PanelView may be ten or twenty years old, it’s still the core of a validated line. Replacing it isn’t simple. In practice, it’s safer and faster to keep that system alive and that’s exactly what we help you do.
Typical failures we see
- HMI displays going dark or freezing mid‑batch
- Drives or servo motors tripping on start‑up
- PLC CPU faults that immediately halt filling, capping or packaging equipment
For each, OEM support often ends years before your validation plan does.
How Obso protects pharma production
- Rapid sourcing: global network for Siemens and Allen Bradley controllers, drives and operator panels.
- Traceability assured: every part comes from verified industrial suppliers with serial control.
- Tested under load: hardware bench‑tested and supplied with documentation.
- Fast turnaround: UK and EU inventory means delivery in days, not months.
Our specialism is providing exact like‑for‑like replacements to avoid the need for re‑validation therefore saving time, cost, and stress.
How to stay validation‑safe
- Maintain a register of all validated equipment (part numbers and firmware versions).
- Flag components now listed as “Mature” or “Discontinued.”
- Source and hold a spare before failure, safer than signing off a change later.
- Confirm supply traceability and warranty for every spare.
We can audit your validated automation inventory and spot risk zones before they halt production.
The cost of downtime vs the cost of planning
| Item | Typical Impact |
| Lost production time | £10 000 – £50 000 per day |
| Discarded batch | From €25 000 upwards |
| Re‑validation requirements | 2 – 6 weeks |
| Cost of spare via Obso Global | Usually < £1 500 and on‑site within days |
Planning ahead is the simplest insurance you can buy.
Summary
Validated systems don’t need replacing every time OEM support ends. They need reliable access to the right spares.
Obso helps pharmaceutical manufacturers keep their approved production lines running – rapidly, securely, and compliantly – even when the OEM has moved on.
Need a fully traceable Siemens or Allen Bradley spare today? Send us the part number; our team will find it and ship promptly to get your line moving again.